Hepatitis Virus Testing Market Size, Share, Growth, Trends, and Global Industry Analysis: By Disease Type (Hepatitis B, Hepatitis C, Hepatitis D, Hepatitis A, and Hepatitis E), By Techniques (Immunoassays, Molecular Assays, and Others), By Modality (Laboratory Based Test and Point-Of-Care Assays), By End User (Hospitals and Clinics, Diagnostic Centers, Blood Banks, and Others), and Region Forecast 2020-2031

Hepatitis Virus Testing Market size was valued at US$ 4.1 million in 2024 and is expected to reach US$ 6.3 million by 2031, growing at a significant CAGR of 6.5% from 2025-2031. The market is a rapidly growing segment of the global diagnostics industry focused on the detection and diagnosis of hepatitis virus infections. Hepatitis is a category of viral diseases that predominantly affect the liver and can cause a wide range of liver damage, from moderate inflammation to severe cirrhosis and even liver failure. Hepatitis viruses are categorized as Hepatitis A, B, C, D, and E. Each type of hepatitis virus has different transmission routes and clinical characteristics, making accurate and timely testing crucial for appropriate patient management and treatment. Hepatitis infections remain a major public health problem across the world, with millions of new cases recorded each year. According to WHO, an estimated 58 million people worldwide have chronic hepatitis C virus infection, with around 1.5 million new infections happening each year.

This high frequency of hepatitis infections is a key factor driving the demand for testing and screening services to detect affected people, ultimately driving the market. Moreover, growing awareness and screening programs coupled with increasing healthcare expenditure contribute to the growth of the testing market. On top of that, growing demand in emerging markets is creating significant opportunities for the growth of the market. However, the high cost of hepatitis virus testing, especially for advanced molecular diagnostic techniques, can be a significant barrier to access hepatitis virus testing. The Companies operating in the market are expanding their product portfolios by offering comprehensive testing solutions.

Key Developments

• In July 2022, Roche introduced new hepatitis C virus diagnostic test the Elecsys HCV Duo immunoassay.
• In November 2021, Molecular Testing Labs launched innovative hepatitis C test options to determine both positivity and viral load.